TAO Synergies TAOX
NASDAQ TAOX
$4.13 +0.12 (+2.99%)
As of: Sep 9, 2026 · 2:42 PM EDT

TAO Synergies (TAOX) Non-Current Assets (2019 - 2026)

TAO Synergies' (TAOX) quarterly Non-Current Assets came in at $486582.0 in Q2 2026, up 4358.33% on a YoY basis from $10914.0 in Q2 2025, and down 39.64% quarter-over-quarter from $806187.0 in Q1 2026.

Analysis

TAO Synergies (TAOX) Non-Current Assets (2019 - 2026) Analysis & Trends

TAO Synergies (TAOX) has reported Non-Current Assets for 8 consecutive years, with $486582.0 the latest figure, recorded in Q2 2026.

  • For the quarter ending Q2 2026, Non-Current Assets rose 4358.33% year-over-year to $486582.0; the trailing twelve-month figure through Jun 2026 stood at $1.8 million (up 202.38% YoY), and the FY2025 full-year result was $456263.0, up 3430.08% from the prior year.
  • Non-Current Assets eased to $486582.0 in Q2 2026 per TAOX's latest filing, from $806187.0 in the prior quarter.
  • Across five years, Non-Current Assets topped out at $806187.0 in Q1 2026 and bottomed at $10111.0 in Q3 2025.
  • Historically, Non-Current Assets has averaged $233315.8 across 5 years, with a median of $21838.5 in 2022.
  • The sharpest annual moves came in 2025 and 2026: Non-Current Assets plunged 98.15% in 2025, then soared 6678.67% in 2026.
  • Over 5 years, Non-Current Assets stood at $22145.0 in 2022, then surged by 2523.2% to $580907.0 in 2023, then slumped by 97.78% to $12925.0 in 2024, then jumped by 3430.08% to $456263.0 in 2025, then increased by 6.65% to $486582.0 in 2026.
  • According to Business Quant data, Non-Current Assets over the past three periods registered $486582.0, $806187.0, and $456263.0 for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Assets (Qtr)
1 Amgen 211.28 Bn 197.29 Bn 7.24 Bn 60.68 Bn
2 Gilead Sciences 181.28 Bn 178.10 Bn 6.22 Bn 35.42 Bn
3 Vertex Pharmaceuticals 132.26 Bn 124.41 Bn 2.84 Bn 14.88 Bn
4 Regeneron Pharmaceuticals 82.58 Bn 74.58 Bn 3.93 Bn 23.28 Bn
5 Argenx Se 61.67 Bn 56.48 Bn 1.37 Bn 1.96 Bn
6 Moderna 54.58 Bn 49.44 Bn 52.00 Mn 5.15 Bn
7 Alnylam Pharmaceuticals 34.01 Bn 30.70 Bn 992.69 Mn 938.60 Mn
8 Biogen 31.26 Bn 29.98 Bn 1.96 Bn 24.78 Bn
9 Roivant Sciences 29.78 Bn 29.78 Bn 1.16 Mn 564.41 Mn
10 TAO Synergies 30.86 Mn 30.86 Mn - 486,582.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 486,582.00
Mar 31, 2026 806,187.00
Dec 31, 2025 456,263.00
Sep 30, 2025 10,111.00
Jun 30, 2025 10,914.00
Mar 31, 2025 11,893.00
Dec 31, 2024 12,925.00
Sep 30, 2024 546,027.00
Jun 30, 2024 559,741.00
Mar 31, 2024 570,908.00
Dec 31, 2023 580,907.00
Sep 30, 2023 19,715.00
Jun 30, 2023 21,438.00
Mar 31, 2023 22,493.00
Dec 31, 2022 22,145.00
Sep 30, 2022 21,532.00
Jun 30, 2022 20,777.00
Mar 31, 2022 19,126.00
Dec 31, 2021 20,445.00
Sep 30, 2021 18,485.00